302 related articles for article (PubMed ID: 26204558)
1. Prevalence and Patient-Level Risk Factors for 30-Day Readmissions Following Free Tissue Transfer for Head and Neck Cancer.
Offodile AC; Pathak A; Wenger J; Orgill DP; Guo L
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):783-9. PubMed ID: 26204558
[TBL] [Abstract][Full Text] [Related]
2. Head and neck microvascular free flap reconstruction: An analysis of unplanned readmissions.
Carniol ET; Marchiano E; Brady JS; Merchant AM; Eloy JA; Baredes S; Park RC
Laryngoscope; 2017 Feb; 127(2):325-330. PubMed ID: 27140439
[TBL] [Abstract][Full Text] [Related]
3. Predictors of 61 unplanned readmission cases in microvascular free tissue transfer patients: multi-institutional analysis of 774 patients.
Kim BD; Ver Halen JP; Lim S; Kim JY
Microsurgery; 2015 Jan; 35(1):13-20. PubMed ID: 24470404
[TBL] [Abstract][Full Text] [Related]
4. Association of Clinical Risk Factors and Postoperative Complications With Unplanned Hospital Readmission After Head and Neck Cancer Surgery.
Bur AM; Brant JA; Mulvey CL; Nicolli EA; Brody RM; Fischer JP; Cannady SB; Newman JG
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1184-1190. PubMed ID: 27737442
[TBL] [Abstract][Full Text] [Related]
5. Readmission following primary surgery for larynx and oropharynx cancer in the elderly.
Chaudhary H; Stewart CM; Webster K; Herbert RJ; Frick KD; Eisele DW; Gourin CG
Laryngoscope; 2017 Mar; 127(3):631-641. PubMed ID: 27659029
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors, Causes, and Costs of Hospital Readmission After Head and Neck Cancer Surgery Reconstruction.
Goel AN; Raghavan G; St John MA; Long JL
JAMA Facial Plast Surg; 2019 Mar; 21(2):137-145. PubMed ID: 30418467
[TBL] [Abstract][Full Text] [Related]
7. Postoperative care fragmentation and thirty-day unplanned readmissions after head and neck cancer surgery.
Graboyes EM; Kallogjeri D; Saeed MJ; Olsen MA; Nussenbaum B
Laryngoscope; 2017 Apr; 127(4):868-874. PubMed ID: 27740687
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for thirty-day readmission following flap reconstruction of oncologic defects of the head and neck.
Osborn HA; Rathi VK; Tjoa T; Goyal N; Yarlagadda BB; Rich DL; Emerick KS; Lin DT; Deschler DG; Durand ML
Laryngoscope; 2018 Feb; 128(2):343-349. PubMed ID: 28850725
[TBL] [Abstract][Full Text] [Related]
9. Hospital readmission after noncardiac surgery: the role of major complications.
Glance LG; Kellermann AL; Osler TM; Li Y; Mukamel DB; Lustik SJ; Eaton MP; Dick AW
JAMA Surg; 2014 May; 149(5):439-45. PubMed ID: 24599504
[TBL] [Abstract][Full Text] [Related]
10. [The use of the platysma myocutaneous flap for reconstruction in the head-neck area -- a retrospective study].
Grützenmacher S; Steinmeier E; Hosemann W
Laryngorhinootologie; 2005 Oct; 84(10):733-7. PubMed ID: 16231240
[TBL] [Abstract][Full Text] [Related]
11. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction.
Graboyes EM; Schrank TP; Worley ML; Momin SR; Day TA; Huang AT
Head Neck; 2018 Jul; 40(7):1366-1374. PubMed ID: 29493825
[TBL] [Abstract][Full Text] [Related]
12. Clinical and financial impact of hospital readmissions after colorectal resection: predictors, outcomes, and costs.
Damle RN; Cherng NB; Flahive JM; Davids JS; Maykel JA; Sturrock PR; Sweeney WB; Alavi K
Dis Colon Rectum; 2014 Dec; 57(12):1421-9. PubMed ID: 25380009
[TBL] [Abstract][Full Text] [Related]
13. Nutritional status in head and neck cancer patients.
Matthews TW; Lampe HB; Dragosz K
J Otolaryngol; 1995 Apr; 24(2):87-91. PubMed ID: 7602677
[TBL] [Abstract][Full Text] [Related]
14. Head and Neck Cancer Patients: Rates, Reasons, and Risk Factors for 30-Day Unplanned Readmission.
Ghiam MK; Langerman A; Sargi Z; Rohde S
Otolaryngol Head Neck Surg; 2018 Jul; 159(1):149-157. PubMed ID: 29787349
[TBL] [Abstract][Full Text] [Related]
15. Sleep apnoea in patients after treatment of head neck cancer.
Steffen A; Graefe H; Gehrking E; König IR; Wollenberg B
Acta Otolaryngol; 2009 Nov; 129(11):1300-5. PubMed ID: 19863328
[TBL] [Abstract][Full Text] [Related]
16. Predictors of readmissions after head and neck cancer surgery: A national perspective.
Chen MM; Orosco RK; Harris JP; Porter JB; Rosenthal EL; Hara W; Divi V
Oral Oncol; 2017 Aug; 71():106-112. PubMed ID: 28688676
[TBL] [Abstract][Full Text] [Related]
17. Readmission after surgery for oropharyngeal cancer: An analysis of rates, causes, and risk factors.
Goel AN; Badran KW; Mendelsohn AH; Chhetri DK; Sercarz JA; Blackwell KE; John MAS; Long JL
Laryngoscope; 2019 Apr; 129(4):910-918. PubMed ID: 30229931
[TBL] [Abstract][Full Text] [Related]
18. Impact of blood transfusions on patients with head and neck cancer undergoing free tissue transfer.
Danan D; Smolkin ME; Varhegyi NE; Bakos SR; Jameson MJ; Shonka DC
Laryngoscope; 2015 Jan; 125(1):86-91. PubMed ID: 25124183
[TBL] [Abstract][Full Text] [Related]
19. [The sentinel node concept in head and neck squamous cell carcinoma--a critical analysis in 100 patients].
Werner JA; Dünne AA; Ramaswamy A; Brandt D; Külkens C; Folz BJ; Moll R; Lippert BM
Laryngorhinootologie; 2002 Jan; 81(1):31-9. PubMed ID: 11845400
[TBL] [Abstract][Full Text] [Related]
20. When to manage level V in head and neck carcinoma?
Naiboğlu B; Karapinar U; Agrawal A; Schuller DE; Ozer E
Laryngoscope; 2011 Mar; 121(3):545-7. PubMed ID: 21344432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
